Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **T cell receptor beta chain Vβ10 region** represents a specific variable domain (TRBV10) of the β chain of the T cell receptor (TCR), which is a heterodimeric membrane receptor complex critical for antigen recognition by T lymphocytes[3][6][7][1]. The Vβ10 region is one variant among many in the TCR beta chain locus, generated through V(D)J recombination, that provides diversity required for broad antigen detection[6][7]. The TCR, including the Vβ10 region, recognizes peptide fragments presented by major histocompatibility complex (MHC) molecules and thereby triggers T cell activation and subsequent immune responses[3][6]. The structural properties of the Vβ domain, including its unique allosteric and signaling features, enable it to influence receptor specificity and sensitivity[1][2]. Therapies targeting the Vβ10 region (e.g., antibody-fusion molecules like STAR0602) can specifically activate or expand T cell subsets expressing this domain, suggesting a role as a therapeutic target in oncology and immunotherapy[5]. Monitoring the frequency or expansion of Vβ10+ T cells is used as a biomarker of immune activation. Therapeutic agents targeting TCR Vβ10 must be designed to limit risks of nonspecific T cell activation, which can result in adverse immunological effects.
Antibody-mediated clustering/cross-linking, resulting in T cell activation and expansion[5]; Modulation of TCR signaling; Enhancement or blockade of antigen-induced T cell responses
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta chain Vβ10 region (TCR Vβ10).